Clinical Trial of the Safety and Efficacy of SP160412 in the Temporary Relief of Mild to Moderate Sunburn

NCT03332524 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

80

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decided to stop for lack of efficacy

Conditions

Sunburn

Interventions

DRUG: SP160412 Ibuprofen 400 mg and Chlorpheniramine maleate 4 mg
DRUG: 2 capsules Ibuprofen and 1 placebo
DRUG: capsule Chlorpheniramine 4mg and 1 Placebo

Sponsor

Sephoris Pharmaceuticals LLC